ABSTRACT
Objective@#To investigate the effect of triptolide on human oral cancer cell (HB) proliferation and phosphates and tensin homologue deleted on chromosome ten gene (PTEN) mRNA expression in oral cancer.@*Methods@#The cancer cells were cultured in the medium containing triptolide of different concentrations for 24, 48 and 72 h. Methyl thiazolyl tetrazolium (MTT) method was used to test the rate of growth inhibition of cancer cells, flow cytometer to detect the change of cell cycle and reveres transcription-PCR (RT-PCR) to examine the expression of PTEN mRNA. The expression of PTEN protein was examined by Western blotting.@*Results@#The rate of growth inhibition was (26.92 ± 0.14)%, (38.67 ± 0.11)%, (72.62 ± 0.89)% and (90.42 ± 0.28)%, respectively. The corresponding expression of PTEN mRNA was (3.59±0.21)%, (5.27±0.40)%, (7.18±0.44)% and (9.16±0.50)%, respectively and the corresponding A value of PTEN protein was 0.135±0.007, 0.410±0.020, 0.447±0.017 and 0.884±0.066, respectively. The proportion of G1 phase cells increased from (58.78±0.98)% to (84.13±0.47)%, but the proportion of S phase cells decreased from (25.40±0.43)% to (9.41±0.73)%.@*Conclusions@#The triptolide not only had inhibitory effect on the HB proliferation, but also affected the cell cycle.
ABSTRACT
Objective To explore the safety and effectiveness of enhanced recovery after surgery (ERAS) after laparoscopic radical gastrectomy for gastric cancer.Methods From January 2014 to December 2015,167 gastric cancer patients undergoing laparoscopic radical gastrectomy with D2 lymphadenectomy were divided into the enhanced recovery after surgery group (ERASG,67 cases) and 102 cases the conventional surgery group (CSG,102 cases).The general status,tumor stage,postoperative recovery,complications,hospitalization time and 30 day readmission were compared between ERASG and CSG.Results The first exhaust time in ERASG and CSG were (2.6 ± 1.1) days and (3.8 ± 1.3) days (t =-6.494,P ＜ 0.01).Statistical analysis showed that there was no significant difference in the postoperative hospitalization time,30 day readmission rate,complications,anastomotic leakage,wound infection,pneumonia,gastric retention and intestinal obstruction between of ERASG and CSG (all P ＞ 0.05).Conclusions Patients in ERASG have quicker postoperative recovery than those in CSG,with similar postoperative complications.
ABSTRACT
BACKGROUND:For patients with rheumatoid arthritis and Kümmel ’s disease, how to effectively control back pain, to recover patient’s locomotor activity and to avoid a vicious cycle of disuse osteoporosis is a key therapeutic target. Kyphoplasty is a recently developed new technology of minimal y invasive spine surgery. Few reports concerned the kyphoplasty for rheumatoid arthritis and Kümmel ’s disease. OBJECTIVE:To assess the clinical outcome of bone cement kyphoplasty for the treatment of Kümmel ’s disease combined with rheumatoid arthritis. METHODS:From June 2012 to July 2013, 11 female patients at the age of 65.4±5.1 years with Kümmel ’s disease combined with rheumatoid arthritis, who suffered from severe back pain, were treated with bone cement vertebroplasty. Back pain and imaging indexes were compared and observed before surgery and during fol ow-up. Imaging indexes contained preoperative and postoperative anterior height of vertebral body after fractures, the ratio of anterior height to posterior height of the vertebral body, and local kyphosis angle (Cobb method). RESULTS AND CONCLUSION:No patients were lost to fol ow up. 11 patients were fol owed up for 6 to 12 months. Significant differences in fol ow-up and preoperative Visual Analogue Scale scores, anterior height of vertebral body after fractures, the ratio of anterior height to posterior height of the vertebral body, and local kyphosis angle were detected (P<0.05). Two patients experienced bone cement leakage. No severe complications appeared such as pulmonary embolism or neurological dysfunction. These data confirmed that bone cement vertebroplasty for rheumatoid arthritis combined with Kümmel ’s disease can effectively lessen back pain, partial y restore the height of vertebral body after fracture, rebuild spinal stabilization, reduce local kyphosis, and is a safe effective repair method.
ABSTRACT
Objective To study the clinical feasibility of micrometer method and thin carbon paper method in the marginal fitness of crown.Methods 10 ex vivo teeth were selected to be restored by Nickel-Chromium alloy PFM crown.Selected 6 measurement sites on shoulder in each ex vivo teeth.Micrometer method,thin carben paper method and SEM method were used to measure.and the data were analyzed by SPSS 13.0.Results 5 data in micrometer method and 6 data in thin carbon paper method were different to SEM method.The disparity was not statistically significant(t=0.392 and t=0.543).Conclusion Micrometer method and thin carbon paper method were two facility quantization measurements to the marginal fitness of crown.They had satisfied to effect in clinic.
ABSTRACT
Objective To observe the neuroprotective effect of celecoxib against degeneration of dopaminergic neurons caused by lipopolysaccharide in vivo.Methods The rat model of Parkinson disease(PD)was established by intranigral injection of lipopolysaccharide.Sprague-Dawley rats were randomly divided into control group,PD group,and celecoxib group.Behavioural changes were recorded,and the expressions of tyrosine hydroxylase(TH)and cyclooxygenase-2(COX-2)were determined by immunohistochmistry and Western blot.Results No behavioral change was found in control group.There was significant difference in the number of circling behavior between PD and celecoxib groups(196.90±9.52 vs 109.30±9.38,P＜0.01).The number of TH-positive cells and the expression of TH protein in rat substantia nigra were significantly higher in celecoxib group than in PD group(P＜0.01).Compared with PD group,the number of COX-2positive cells and the expression of COX-2 protein were significant lower in celecoxib group(P＜0.01).Conclusion Celecoxib has neuroprotective effect on the degeneration of dopaminergic neurons caused by lipopolysaccharide in vivo.